ALVO Alvotech Biopharmaceuticals Gross Profit Margin

Official company branding of Alvotech S.A. (ALVO)

Stable demand for biosimilars, driven by their inclusion in medical formularies, creates long-term rent for Alvotech. The gross margin illustrates current profitability, with 56.80 serving as the current value of this metric. This result is supported by flawless thermostable drug delivery and a discounting pricing strategy for insurance companies, which determines the business's final margin.

Alvotech Corp (ALVO) - Gross Margin from 04/28/2023 to 11/19/2026

Financial and market metric breakdowns for Alvotech (ALVO)

- share price and consensus valuation forecast:
Fundamental valuation:Alvotech
Core merchandise of Alvotech Biopharmaceuticals

Alvotech is aggressively capturing biosimilar niches, intentionally lowering prices to displace original drugs. The stability of the gross margin here reflects the efficiency of production cost controls relative to revenue, where any narrowing of this gap signals a decline in operational resilience and rising default risks, directly impacting the company's cost of debt.

Main competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Liquidia Inc. - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin